Dynamic Technology Lab Private Ltd Purchases Shares of 1,250 Chemed Corporation $CHE

Dynamic Technology Lab Private Ltd bought a new position in shares of Chemed Corporation (NYSE:CHE) in the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm bought 1,250 shares of the company’s stock, valued at approximately $560,000.

Several other large investors also recently modified their holdings of CHE. Geneos Wealth Management Inc. raised its stake in shares of Chemed by 330.4% in the first quarter. Geneos Wealth Management Inc. now owns 99 shares of the company’s stock worth $61,000 after purchasing an additional 76 shares during the last quarter. Savant Capital LLC bought a new position in shares of Chemed during the 2nd quarter valued at approximately $378,000. AGF Management Ltd. purchased a new stake in Chemed in the second quarter worth $2,432,000. Parkside Financial Bank & Trust raised its stake in Chemed by 86.3% in the 2nd quarter. Parkside Financial Bank & Trust now owns 95 shares of the company’s stock valued at $46,000 after acquiring an additional 44 shares during the period. Finally, Connor Clark & Lunn Investment Management Ltd. purchased a new stake in shares of Chemed during the 2nd quarter valued at approximately $2,992,000. Institutional investors and hedge funds own 95.85% of the company’s stock.

Wall Street Analyst Weigh In

CHE has been the topic of a number of analyst reports. Zacks Research lowered shares of Chemed from a “hold” rating to a “strong sell” rating in a report on Wednesday, March 4th. Jefferies Financial Group lowered shares of Chemed from a “buy” rating to a “hold” rating in a research report on Thursday, January 22nd. Oppenheimer cut their target price on shares of Chemed from $580.00 to $500.00 and set an “outperform” rating on the stock in a report on Friday, February 27th. Royal Bank Of Canada reiterated a “sector perform” rating and issued a $422.00 price objective (down from $572.00) on shares of Chemed in a report on Friday, February 27th. Finally, Weiss Ratings restated a “hold (c-)” rating on shares of Chemed in a research note on Wednesday, January 21st. Two investment analysts have rated the stock with a Buy rating, three have assigned a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, Chemed presently has a consensus rating of “Hold” and an average price target of $498.00.

Chemed Trading Down 0.6%

CHE stock opened at $400.88 on Wednesday. The stock’s 50 day simple moving average is $442.99 and its 200 day simple moving average is $441.90. Chemed Corporation has a 12-month low of $385.00 and a 12-month high of $623.60. The stock has a market capitalization of $5.52 billion, a PE ratio of 21.82, a price-to-earnings-growth ratio of 1.60 and a beta of 0.46.

Chemed (NYSE:CHE) last posted its quarterly earnings results on Wednesday, February 25th. The company reported $6.42 earnings per share for the quarter, missing the consensus estimate of $7.02 by ($0.60). The business had revenue of $639.34 million during the quarter, compared to analysts’ expectations of $659.09 million. Chemed had a return on equity of 25.66% and a net margin of 10.48%.The firm’s revenue for the quarter was down .1% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $6.83 EPS. Chemed has set its FY 2026 guidance at 23.250-24.250 EPS. On average, research analysts predict that Chemed Corporation will post 21.43 earnings per share for the current year.

Chemed Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, March 13th. Investors of record on Monday, February 23rd will be issued a $0.60 dividend. The ex-dividend date is Monday, February 23rd. This represents a $2.40 annualized dividend and a yield of 0.6%. Chemed’s dividend payout ratio (DPR) is currently 13.06%.

Chemed Company Profile

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.